Overview

Clinical Study of Nanocrystalline Megestrol in Malnourished Patients With First-Line Non-Small Cell Lung Cancer

Status:
NOT_YET_RECRUITING

Trial end date:
2027-04-30

Target enrollment:

Participant gender:

Summary

This prospective interventional clinical study evaluates the efficacy of nanocrystalline megestrol combined with standard care in improving appetite and weight compared to standard care alone in first-line treatment of NSCLC.

Phase:

PHASE3

Details

Lead Sponsor:

Hunan Province Tumor Hospital

Treatments:

Drug Therapy